Clinical Trial Update: Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nimotuzumab in combination with chemoradiation for nasopharyngeal cancer; current status is UNKNOWN according to ClinicalTrial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Nasopharyngeal Cancer | Phase 3 | Status: UNKNOWN